Market Overview
The global thyroid ablation device market was valued at USD 159 million in 2024 and is projected to reach USD 216 million by 2031, exhibiting a CAGR of 4.5% during the forecast period. This growth is primarily driven by the rising incidence of thyroid disorders globally, particularly thyroid nodules and cancer. The American Cancer Society estimates approximately 44,020 new cases of thyroid cancer will be diagnosed in the US in 2024, driving demand for minimally invasive treatment options like ablation.
Thyroid ablation devices use various energy modalities to destroy targeted thyroid tissue. Radiofrequency ablation (RFA) devices accounted for the largest market share (approximately 55%) in 2024, with microwave ablation (MWA) devices showing the fastest growth. The procedure is typically performed using a needle-like electrode inserted into the tissue, where high-frequency radio waves generate heat and destroy the target tissue. This minimally invasive approach offers significant advantages over traditional surgery, including shorter recovery times, reduced complication rates, and preservation of healthy thyroid tissue.
216 million by 2031 USD 159 million in 2024
of 4.5%
Radiofrequency Ablation Devices
Microwave Ablation Systems
Radiofrequency Ablation Devices dominate the market due to their precision in targeting thyroid nodules while minimizing damage to surrounding tissues. Their adoption is driven by superior safety profiles and predictable ablation zones that give physicians greater control during procedures.
By Application
Thyroid Nodule Ablation
Thyroid Cancer Treatment
Hyperthyroidism Management
Research & Development
Thyroid Nodule Ablation represents the largest application segment as these devices enable minimally invasive treatment of benign nodules that would traditionally require surgery. The technology's growth is fueled by increasing preference for scar-free procedures and outpatient treatment settings that reduce hospital stays and healthcare costs significantly.
Portable Neuromonitoring Device Market
https://www.24lifesciences.com
Our Key Players
Medtronic plc (Ireland)
Boston Scientific Corporation (US)
Johnson & Johnson (US)
Abbott Laboratories (US)
Varian Medical Systems, Inc. (US)
